Arisaph Pharmaceuticals Garners $10,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=849f1ca0-9beb-47c5-8878-daa9b738268d Date 11/1/2013 Company Name Arisaph Pharmaceuticals Mailing Address 100 High Street Boston, MA 02110 Company Description Arisaph Pharmaceuticals, Inc. is an emerging drug discovery and design biopharmaceutical company located in Boston, Massachusetts, an internationally recognized center of biotechnology. The company utilizes proprietary drug discovery platforms to develop differentiated drugs that are … Continue reading “Arisaph Pharmaceuticals Garners $10,000,000 New Round”

Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy

It wasn’t too long ago that the words gene therapy would send VC investors running for cover. Clearly, times are changing, because today, a new startup named Dimension Therapeutics has become the second company in the space to come out of the woodwork with significant venture backing since July. Cambridge, MA-based Dimension was formed today … Continue reading “Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy”

Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues

The latest domino in the Ariad Pharmaceuticals (NASDAQ: [[ticker:ARIA]]) saga fell this morning, as the company yanked its troubled, flagship cancer drug ponatinib (Iclusig) from the market. Cambridge, MA-based Ariad said today that it has “temporarily” suspended the marketing and commercial distribution of ponatinib due to a request from the FDA yesterday afternoon. Ponatinib, Ariad’s … Continue reading “Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues”

Alector Goes After Alzheimer’s, With Cash from Polaris & OrbiMed

Alzheimer’s disease scares the bejesus out of millions of aging Baby Boomers, who fear they’ll lose their memories and everything that makes them who they are. The biology of the disease has stumped researchers and pharma companies for years. The field is crying out for fresh entrepreneurial thinking. Now a couple prominent biotech entrepreneurs are … Continue reading “Alector Goes After Alzheimer’s, With Cash from Polaris & OrbiMed”

Red (and Green) Flags To Look for With Biotech’s Buyside Investors

As Warren Buffett once pointed out, companies get the investors they deserve. Observations by the oracle-from-Omaha are hard to dispute, but how does that translate into practice if you’re a biotech company going through the IPO process and trying to read the signs in a whole new landscape of investors known as “the buyside”? Many … Continue reading “Red (and Green) Flags To Look for With Biotech’s Buyside Investors”

NanoComp Technologies Secures $6,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=736f99c8-b9a3-4c33-ab60-6d4c0d1cbde3 Date 10/31/2013 Company Name NanoComp Technologies Mailing Address 57 Daniel Webster Highway Merrimack, NH 03054 Company Description NanoComp Technologies Inc (NCTI) was formed in 2004 as a spin-out of Synergy Innovations, Inc. a Concord, NH based technology development company. NCTI’s purpose is to leverage its proprietary and fundamental advancements in the … Continue reading “NanoComp Technologies Secures $6,000,000 New Funding”

Rethink Robotics Obtains $11,500,002 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1ad3a824-8a80-41ad-a682-7ef5086255c4 Date 10/31/2013 Company Name Rethink Robotics Mailing Address 27 Wormwood St. Boston, MA 02210 Company Description Rethink Robotics is combining the power of computers – embodied in robots – and the extraordinary intelligence of the American workforce, to increase productivity and revitalize manufacturing. Website http://www.rethinkrobotics.com Transaction Type Venture Equity Transaction Amount … Continue reading “Rethink Robotics Obtains $11,500,002 New Round”

Knome Lands $5,752,500 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=566b9a66-0b15-43f4-a224-facdb8e327ea Date 10/31/2013 Company Name Knome Mailing Address 25 First Street Cambridge, MA 02141 Company Description Knome provides whole genome sequencing and analysis services to biomedical researchers and motivated families seeking to understand the genetic underpinnings of human disease. Led by internationally recognized scientists, clinicians and bioinformaticians, Knome has been responsible for … Continue reading “Knome Lands $5,752,500 New Financing Round”

Boston Tech Roundup: Narvii, Q Factor, SiteSpect, & More

This week is, shall we say, eventful in Boston. There’s the MassChallenge awards gala tonight, something else going on at Fenway, and the MassTLC unConference on Friday. Apart from all that, here’s the news: —Q Factor Communications, a Waltham, MA-based startup working on software to improve video (and other rich media) delivery to smartphones and … Continue reading “Boston Tech Roundup: Narvii, Q Factor, SiteSpect, & More”

Merrimack’s Cancer Drug Misses Mark in Mid-Stage Trial, Shares Tumble

Merrimack Pharmaceuticals has been keeping a close eye on an ongoing series of mid-stage clinical trials of its experimental cancer drug, hoping they will prove its worth to regulators and investors. It released the results from one of those studies today, and the numbers aren’t pretty. Cambridge, MA-based Merrimack (NASDAQ: [[ticker:MACK]]) said today that the … Continue reading “Merrimack’s Cancer Drug Misses Mark in Mid-Stage Trial, Shares Tumble”

Four Red Flags for Digital Health Investors

It’s been a banner year for startups raising money to start digital and mobile health businesses—enough to spark a recent Time magazine article called “The Obamacare Start-Up Boom.” Here in San Francisco, it seems the number of job applicants my own digital heatlh company receives, as well as the number of attendees at health technology … Continue reading “Four Red Flags for Digital Health Investors”

Q Factor Communications Obtains $6,500,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a71bb7d8-02fd-45cb-9645-65c38d8f6859 Date 10/30/2013 Company Name Q Factor Communications Mailing Address 255 Bear Hill Rd. Waltham, MA 02541 Company Description Q Factor radically improves user experiences over today’s increasingly congested wireless networks (2G/3G/4G+WIFI) by streamlining the delivery of content. As the world becomes more-and-more unwired, users still expect their browsing or viewing experiences … Continue reading “Q Factor Communications Obtains $6,500,000 New Financing Round”

Novogy Garners $2,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e4fa4e9-baf7-4e43-9926-7071a9cd04e8 Date 10/30/2013 Company Name Novogy Mailing Address 85 Bolton Street Cambridge, MA 02138 Company Description The company is developing cellulosic fuel technologies and is focused on waste-paper sludge as a feedstock. Website http://www.novogyinc.com Transaction Type Debt Transaction Amount $2,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory … Continue reading “Novogy Garners $2,000,000 New Financing”

PathoGenetix Garners $10,000,000 Series C Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=023151c3-cf33-4306-9b7b-9858b7382caf Date 10/30/2013 Company Name PathoGenetix Mailing Address 12 Gill Street Woburn, MA 01801 Company Description PathoGenetix has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company’s innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring. Addressable segments of these … Continue reading “PathoGenetix Garners $10,000,000 Series C Financing Round”

Three Funding Terms Every Startup Should Understand

We’ve seen tremendous growth in the number of new startups in recent years, but the pool of VC funding is not keeping pace with this growth. This can put cash-starved startups at a disadvantage when it comes to negotiating company-favorable investment terms from VCs. But regardless of how eager founders may be to secure the … Continue reading “Three Funding Terms Every Startup Should Understand”

Harvest Automation Hauls In $11.75M More to Advance Ag Robots

Score one for the Boston robotics scene. And for the future of agricultural robots. Harvest Automation, the pride of North Billerica, MA, has raised $11.75 million in Series C funding led by Mousse Partners Limited of New York. Harvest’s previous investors, which include Life Sciences Partners, Cultivian Ventures Founder Collective, and MassVentures, also participated in … Continue reading “Harvest Automation Hauls In $11.75M More to Advance Ag Robots”

Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop

Vertex Pharmaceuticals had a brief moment in the sun with its hepatitis C drug, and now that it’s coming to an end, the company is making some big job cuts. Cambridge, MA-based Vertex (NASDAQ: [[ticker:VRTX]]) said today it is cutting 370 jobs, about 15 percent of its workforce, after a dismal third-quarter sales performance for … Continue reading “Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop”

Precipio Diagnostics Garners $1,800,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d8cf7f9-da7d-4dd2-9bba-85017f87fea0 Date 10/29/2013 Company Name Precipio Diagnostics Mailing Address 4 Science Park 3rd Floor New Haven, CT 06511 Company Description Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the … Continue reading “Precipio Diagnostics Garners $1,800,000 Series B Financing”

Harvest Automation Receives $11,750,000 Series C Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37113f12-e3d4-4599-b60c-a0d2f8990d99 Date 10/29/2013 Company Name Harvest Automation Mailing Address 85 Rangeway Road Billerica, MA 01862 Company Description Harvest Automation is a material handling robotics company which is focused on a new category of robots we call Cooperative Robots. Website http://www.harvestautomation.com Transaction Type Venture Equity Transaction Amount $11,750,000 Transaction Round Series C Proceeds … Continue reading “Harvest Automation Receives $11,750,000 Series C Funding Round”

Precipio Diagnostics Obtains $1,800,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d8cf7f9-da7d-4dd2-9bba-85017f87fea0 Date 10/29/2013 Company Name Precipio Diagnostics Mailing Address 4 Science Park 3rd Floor New Haven, CT 06511 Company Description Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the … Continue reading “Precipio Diagnostics Obtains $1,800,000 Series B Funding”

Red Sox Nutritionist on Sports, Stress, & Segterra (and World Series)

Like a lot of people in New England, Tara Mardigan didn’t get much sleep Sunday night. “It’s 1 a.m. and you’re still thinking about Jonny Gomes sending it out of the park,” she says. (The dramatic home run pushed the Red Sox to a 4-2 victory over St. Louis, tying the World Series at two … Continue reading “Red Sox Nutritionist on Sports, Stress, & Segterra (and World Series)”

Google Ventures, Andreessen-Backed Openbay Aims to Fix Car Repair

It seems like there are a million little small-business headaches that haven’t been solved by the Internet quite yet. There’s a good reason for that—signing up small businesses can be a serious slog, even aside from the structural problems of building a two-sided marketplace where you bring together buyers and sellers. But eventually, you have … Continue reading “Google Ventures, Andreessen-Backed Openbay Aims to Fix Car Repair”

The Biggest Bargains Pharma Scooped Up in the Down Years

Most little biotech companies, until this year’s IPO boom, couldn’t seriously think about raising money from public investors. Most couldn’t raise big venture dollars from an ever-shrinking pool of VCs. The pool of potential partners and buyers in Big Pharma was shrinking, too, because mega-mergers reduced the number of potential bidders. With cash running low … Continue reading “The Biggest Bargains Pharma Scooped Up in the Down Years”

Iontera Garners $600,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66f8ccaa-5270-4415-9c8e-c9e732e13802 Date 10/28/2013 Company Name Iontera Mailing Address 1 Richmond Square Providence, RI 02903 Company Description Iontera is the maker of BIOBLISS, a toxin-free skin rejuvenation via transdermal patch technology. The BIOBLISS Patch operates using its proprietary ion technology, gently pushing dermatologist-approved anti-wrinkle ingredients to the skin reducing the appearance of wrinkles … Continue reading “Iontera Garners $600,000 New Funding Round”

From Flybridge to Foundation: Michael Greeley Talks VC Transition

Seismic shifts are occurring in the venture capital world. Here in Boston, the tectonic plates of healthcare and software/IT funds just moved a little farther apart. Longtime healthcare technology VC Michael Greeley is leaving Flybridge Capital Partners, the firm he co-founded in 2001 (as IDG Ventures Atlantic), to join Foundation Medical Partners, a Connecticut-based venture … Continue reading “From Flybridge to Foundation: Michael Greeley Talks VC Transition”

Boston Roundup: Sqrrl, Panorama, Superpedestrian, Threat Stack, & More

[Updated 11:25 am] We’ve got a flurry of fundraising news to round out the week, along with word of some venture partner departures: —Sqrrl, a secure database software company founded by former National Security Agency computer scientists, has raised $5.2 million in Series A financing. The investment was led by Atlas Venture and Matrix Partners, … Continue reading “Boston Roundup: Sqrrl, Panorama, Superpedestrian, Threat Stack, & More”

East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More

The headline of the year in biotech has been IPOs. But this week, the news centered around a bunch of companies at the other end of the journey from startup to public company, those just coming out of the woodwork. Those stories and more below: —Cambridge, MA-based Pronutria emerged from stealth mode this week. Flagship … Continue reading “East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More”

BuzzFeed, and 4 More Bad Startup Ideas that Look Like Good Ideas

Y Combinator staged its annual Startup School event last Saturday, attracting more than 1,700 young startup founders and would-be founders. Andreessen Horowitz partner (and Xconomist) Chris Dixon, the founder of Web startups SiteAdvisor (sold to McAfee) and Hunch (sold to eBay), gave one of the most interesting talks, under the title “Good Ideas That Look Like Bad … Continue reading “BuzzFeed, and 4 More Bad Startup Ideas that Look Like Good Ideas”

ByteLight Receives $3,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eff9fdd8-0362-47e6-bec9-46e2a0581f4f Date 10/25/2013 Company Name ByteLight Mailing Address 1 Cambridge Center 6th Floor Cambridge, MA 02142 Company Description Based in Cambridge, MA, Bytelight is a provider of market-leading indoor positioning solutions using an innovative LED lighting based technology. ByteLight’s solution leverages the existing lighting infrastructure to deliver unprecedented accuracy and responsiveness. Website … Continue reading “ByteLight Receives $3,000,000 Series A Round”

Decisyon Lands $7,145,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b095f0b2-717a-496c-a26a-d95e4f9742a4 Date 10/25/2013 Company Name Decisyon Mailing Address 1266 East Main Street Stamford, CT 06902 Company Description Decisyon’s unique software allows its customers to drive significant financial and operational benefits by quickly discovering the key factors affecting business issues and processes, collaborating and deciding on the best course of action, and executing … Continue reading “Decisyon Lands $7,145,000 New Financing”

Marginized No More: Nextly Wants to Be Your Guide to Web Content

After a proverbial pivot, Ziad Sultan is back on the trail, looking to harness the social Web to help people browse information more efficiently. The founder of Cambridge, MA-based Marginize has morphed his company into a new entity. It’s called Nextly, and it has raised $1.5 million from Sultan’s previous investors (on top of about … Continue reading “Marginized No More: Nextly Wants to Be Your Guide to Web Content”

Amid Lawsuit Settlement Talks, Formlabs Raises $19M

It looks like 3D printing startup Formlabs could be nearing the end of its time stuck in legal limbo. The Somerville, MA-based company—one of the more notable names in the latest wave of cheaper 3D printing—has significantly added to its bank account with a $19 million private investment. That infusion of cash comes amid a … Continue reading “Amid Lawsuit Settlement Talks, Formlabs Raises $19M”

Andy Ory Leaves Oracle, Talks Thinking Phones & Acme Packet Sale

Andy Ory has surfaced at last. The wildly successful tech entrepreneur, he of Acme Packet CEO fame, has left Oracle as of the end of August and is taking what he calls a “sabbatical” of six to nine months to recharge and get ready for the next big thing. In case you forgot, Bedford, MA-based … Continue reading “Andy Ory Leaves Oracle, Talks Thinking Phones & Acme Packet Sale”

coUrbanize Obtains $550,806 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dfd46cfb-049a-4163-a3d4-21dc0f71d8ef Date 10/24/2013 Company Name coUrbanize Mailing Address One Cambridge Center Boston, MA 02139 Company Description coUrbanize tracks the process of real estate development and planning projects and gathers public input from users with verified accounts in a data-driven, fact-based platform to add transparency to the decision-making process. Website http://www.courbanize.com Transaction Type … Continue reading “coUrbanize Obtains $550,806 New Financing”

Rage Frameworks Lands New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c89bd571-cb2a-4293-8099-3801c7a7af8f Date 10/24/2013 Company Name Rage Frameworks Mailing Address 200 Lowder Brook Dr. Westwood, MA 02090 Company Description We provide enterprise mission critical Business Process Automation and Big Data solutions and products as a managed service, based on our pioneering and patented technology. Website http://www.rageframeworks.com Transaction Type Venture Equity Transaction Amount Undisclosed … Continue reading “Rage Frameworks Lands New Funding Round”

Formlabs Obtains $19,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=086b5f39-dedb-4fa4-a30d-66dcf00a2f54 Date 10/24/2013 Company Name Formlabs Mailing Address 288 Norfolk Street Cambridge, MA 02139 Company Description The company, which has no website of its own yet, is working on making a low-cost 3D printer that is intended to be affordable enough that “everyday people” could use it to make three dimensional forms, … Continue reading “Formlabs Obtains $19,000,000 Series A Round”

Alzheon Secures New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4587c278-37e7-41a9-ae56-86adfdecdb9c Date 10/24/2013 Company Name Alzheon Mailing Address 394 Lowell St Lexington, MA 02420 Company Description Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. We are building a pipeline of innovative drugs to target the underlying pathogenesis … Continue reading “Alzheon Secures New Financing”

MediaCrossing Garners $6,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e2e65151-c7b2-4a8b-b419-a8c108411fda Date 10/24/2013 Company Name MediaCrossing Mailing Address 300 Main Street Stamford, CT 06901 Company Description MediaCrossing Inc. is building an important new company in an exciting new category–independent media trading and market making–in the fast-growing multi-billion dollar global digital ad market. Website http://www.mediacrossing.com Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction … Continue reading “MediaCrossing Garners $6,000,000 New Funding Round”

NextCODE Lands $15,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=55331045-1e87-4821-a376-d0f7e3a9c9ab Date 10/24/2013 Company Name NextCODE Mailing Address One Broadway 14th Floor Cambridge, MA 02142 Company Description NextCODE Health is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. Using technology developed over more than 16 years at deCODE genetics, we are enabling the widespread … Continue reading “NextCODE Lands $15,000,000 Series A Funding Round”

Nutonian Garners $4,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2c73ca74-9f37-4b10-92b1-f88eca0fbf0a Date 10/24/2013 Company Name Nutonian Mailing Address 25 1st St Cambridge, MA 02141 Company Description Founded in 2011 by two of the world’s best data scientists (Forbes), Nutonian has developed a breakthrough technology that enables anyone to uncover and explain the intrinsic relationships hidden within complex data. The ability to not … Continue reading “Nutonian Garners $4,000,000 Series A Round”

DeCode Spinout, NextCode Health, Launches With $15M From Arch, Polaris

Arch Venture Partners and Polaris Partners got a windfall when they snatched deCode Genetics out of bankruptcy and flipped it to Amgen (NASDAQ: [[ticker:AMGN]]) for $415 million a few years later. Now the two VC firms think there’s still more value in the genomics platform deCode assembled, and have helped form a new startup, NextCode … Continue reading “DeCode Spinout, NextCode Health, Launches With $15M From Arch, Polaris”

North Bridge Gets $580M for Second Growth Equity Fund

[Corrected headline dollar figure] Waltham, MA-based North Bridge Growth Equity has raised a second fund, saying it has more than $580 million in committed cash to bankroll growing companies that have a technology focus. North Bridge’s growth equity arm got its start with a $545 million fund, which was raised in 2007. It lists 12 portfolio companies … Continue reading “North Bridge Gets $580M for Second Growth Equity Fund”

Buzzcar’s Robin Chase Drops by Springboard’s Opening Night in New York

When Robin Chase comes to town, expect lessons in influence and driving change in executive leadership. Chase—the co-founder of Zipcar and founder of Buzzcar—spoke last night at a reception in New York ahead of Wednesday’s Springboard Annual Forum. Addressing the women-led media and tech startups that graduated from the Springboard Enterprises accelerator, Chase offered a … Continue reading “Buzzcar’s Robin Chase Drops by Springboard’s Opening Night in New York”

Nutonian CEO: Business and Science Face Same Big-Data Problem

Is “big data” starting to fade away as a tech-business theme? Hardly. A couple of Boston-area startups in the field just announced Series A funding rounds this week. Sqrrl, a Cambridge, MA-based company founded by former NSA scientists, raised $5.2 million from Atlas Venture and Matrix Partners. The startup has developed a new kind of … Continue reading “Nutonian CEO: Business and Science Face Same Big-Data Problem”

Pharma Showing Interest in Open Systems for Drug Discovery

[Editor’s note: this post first appeared on the FasterCures blog.] Bringing the ideas of “open source” into the pharmaceutical process is far from simple. It requires a careful understanding both of the realities of open source as a software development process well as the realities of therapy research, development, and regulatory approval. The open source … Continue reading “Pharma Showing Interest in Open Systems for Drug Discovery”

WiTricity’s Wireless-Power Tech Attracts $25M from Intel, Foxconn

It’s been many years since Nikola Tesla’s heyday, and despite the mind-blowing advancements in many areas of technology, we’re still plugging things in with electric cords like a bunch of savages. Wireless power charging is technically possible. But it’s still not here in a widespread sense—one of those advancements that you check in on once … Continue reading “WiTricity’s Wireless-Power Tech Attracts $25M from Intel, Foxconn”

Alzheon Emerges From Stealth, Hunts for Alzheimer’s Castoffs

Clinical trial flops have become the norm for Alzheimer’s disease treatments, despite the billions put into research for the memory-robbing disorder. But a new Lexington, MA-based startup called Alzheon sees opportunity in all of those high-profile failures of the past. Its belief is that these failures have left behind a treasure trove of clinical data, … Continue reading “Alzheon Emerges From Stealth, Hunts for Alzheimer’s Castoffs”

WiTricity Receives Series E Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=566918eb-005d-45d3-a03b-841061dd0555 Date 10/23/2013 Company Name WiTricity Mailing Address 149 Grove Street Watertown, MA 02472 Company Description The company is developing technology to transmit energy wirelessly. Website http://www.witricitynet.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Series E Proceeds Purposes The funding will support the company’s growth strategy as it further develops … Continue reading “WiTricity Receives Series E Funding”